Early Access — free while we kick the tires
EdgarHawk

Upton Richard A

Director

Director
3 filings analyzed · 1 company · Latest 2024-09-16

Companies

Company Buys Sells Direction
Carmell Corp XAGE 4 0 Net buying

Activity

September 2024
2024-09-16 Carmell Corp XAGE
low
Buy
5,000 shares
$2,336
Significance 3/10

Director Upton Richard A bought 5,000 shares of CTCX at $0.47 on 2024-09-13; stock down -91.2% from 52-week high.

Director Upton Richard A purchased 5,000 shares at $0.47 on 2024-09-13, increasing his holdings to 15,000 shares. The stock has collapsed to $0.43 (current price), down -91.2% from its 52-week high of $4.87, and his purchase price was reached after a -55.0% decline over the preceding 30 days. His prior trades at CTCX show a poor track record: of his 3 measurable prior purchases at this ticker, none achieved positive 90-day returns, with outcomes ranging from -22.3% to -78.7% over 90 days. His broader cross-ticker buy track record is similarly weak: 0 of 4 prior buys had positive 90-day returns, averaging -44.3%. The company is unprofitable (net income of $-3,304,538.00 over the latest full fiscal year) with minimal revenue of $12,320.00 in the latest quarter and a market cap of $8,989,325.01. While a cluster of 5 other insiders also bought within the past 14 days, Upton's own purchase pattern at this ticker shows consistent inability to time entry points favorably, raising questions about the quality of this incremental deployment.

August 2024
2024-08-21 Carmell Corp XAGE
medium
Buy
3,600 shares
$3,218
Significance 4/10

Director Upton buys 3,600 shares of CTCX at $0.89; stock down -85.6% from 52-week high, cluster activity detected

Director Richard A Upton purchased 3,600 shares of Carmell Corp at $0.89 on 2024-08-20, increasing his holdings by 56.2% to 10,000 shares post-transaction. The stock has since fallen to $0.70 (a -22.5% loss on this purchase) and is trading -85.6% from its 52-week high of $4.87, reflecting severe deterioration in valuation over the past year. Upton's prior trades at CTCX showed negative returns at the 90-day mark in both measurable instances (30d -17.0%, 90d n/a on the June 2024 buy; and 90d -32.0% and -22.3% on the December 2023 purchases), establishing a pattern of poorly-timed entry points at this ticker. The company is unprofitable, with net income of $-3,304,538.00 in its most recent fiscal year, making this a speculative position in a distressed security. The filing also reports cluster activity, with 2 other insiders buying within the past 14 days, though this alone does not confirm coordinated conviction.

June 2024
2024-06-14 Carmell Corp XAGE
high
Buy
2,000 shares
$4,409
Significance 4/10

Director Richard Upton buys 2,000 shares of CTCX at $2.20; stock now at $1.99, -79.6% from 52-week high amid unprofitable operations.

Director Richard A Upton purchased 2,000 shares at $2.20 on 2024-06-12, increasing holdings to 54,445 shares, while the current price of $1.99 reflects a -79.6% decline from the 52-week high of $9.74. Carmell Corp's fundamentals are severely challenged: the company reported revenue of $3,728,816.00 and net income of $-3,270,959.00 in its latest quarter, with negative full-year net income, signaling sustained operational losses. Upton's prior two purchases at CTCX (December 2023) both produced negative 90-day returns (-32.0% and -22.3% respectively), establishing a pattern where his purchases at this ticker have not arrested subsequent declines. The current buy occurs amid a 30-day price decline of -14.6%, and 2 other insiders have also bought within 14 days, though the clustering does not offset the backdrop of unprofitable operations and Upton's failed timing on prior CTCX purchases.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access